AI-Native Scoping Reviews & Evidence Mapping

Buttock augmentation safety is not defined by aesthetics alone: this evidence map shows that risk concentrates around where material is placed and what material is used, with subcutaneous image-guided fat grafting looking far safer than intramuscular injection or illicit permanent fillers. The full read separates low-complication fat-grafting and implant techniques from the dangerous edge cases — fat embolism, silicone embolism, septic shock, granulomatous hypercalcemia, sciatic nerve injury, and difficult filler migration — giving clinicians and patients a practical map of where buttock augmentation becomes unsafe.

Hair transplantation is no longer a simple choice between FUE and FUT, but a patient-specific technical workflow shaped by donor reserve, graft handling, recipient-site geometry, anesthesia, regenerative adjuncts, and reconstructive goals. This evidence map helps readers see which techniques are supported by original data, where survival and satisfaction signals are strongest, and where the field still needs better comparative trials.

Laser epilation is no longer just a cosmetic hair-removal procedure — this evidence map shows how it extends into pilonidal disease prevention, reconstructive surgery, trichiasis care, inflammatory follicular disorders, and phototype-adapted clinical practice. Built from **83 references and 113 original studies**, the full map helps readers see where laser hair removal is effective, where durability remains uncertain, and where safety risks such as ocular injury, burns, paradoxical hypertrichosis, pigmentary effects, and topical-anesthetic toxicity require protocol-driven care.

Seborrheic dermatitis is more than dandruff or simple fungal overgrowth: this evidence map shows a recurrent inflammatory disease shaped by Malassezia dysbiosis, barrier/lipid dysfunction, immune activation, Staphylococcus signals, and psychosocial burden. The full SAIMSARA evidence map is worth reading because it separates stronger treatment signals — ketoconazole, ciclopirox, selenium disulfide, calcineurin inhibitors, isotretinoin, roflumilast foam, and barrier repair — from emerging or heterogeneous findings across 706 original studies.